during the past year 25 patients with advanced transitional cell carcinoma were treated with intravenous doxorubicin hydrochloride ( adriamycin ) , 60 to 75 mg. per square meter of body surface area , every three weeks .
C0546861
doxorubicin hydrochloride
C0085752
adriamycin